Vitamin D and Multiple Sclerosis Risk


Reduced vitamin D levels may be related to multiple sclerosis (MS) risk, according to findings published in PLOS One.

Reduced vitamin D levels may be related to multiple sclerosis (MS) risk, according to findings published in PLOS One.

A multifaceted team of researchers used Mendelian randomization to genetically reduce the possibility of confounding in order to evaluate whether or not there was a link between genetically reduced vitamin D levels and the susceptibility to MA. The patients were all participants in the Multiple Sclerosis Genetics Consortium study, and international group of almost 15,000 patients with MS and nearly 25,000 healthy controls. The authors explained that the randomization method they utilized allowed them to avoid the possibility of confounding or reverse causation.

The researchers said their observational evidence pointed towards the fact that lower vitamin D levels are linked to an increased risk of MS. However, the study did not evaluate whether vitamin D can modulate the course of MS after its onset.

“Genetically lowered vitamin D levels are strongly associated with increased susceptibility to MS,” the authors wrote. “Whether vitamin D sufficiency can delay, or prevent, MS onset merits further investigation in long term randomized controlled trials.”

However, one of the limitations of the study, the authors explained, was the range of assumptions the team made during the analysis (citing their study population — the research may not apply to patients outside of non-European ancestry). They didn’t expand on any other details in the press release describing the study.

The authors also noted that previous research conducted about the relationship between vitamin D and MS risk determined that there may be a link. They continued that a causal relationship would be difficult to pinpoints, though, because the patients that develop MS may have been influenced by other factors outside of isolating their vitamin D status.

“Ongoing randomized controlled trials are currently assessing vitamin D supplementation for the treatment and prevention of MS ... and may therefore provide needed insights into the role of vitamin D supplementation,” the authors concluded.

Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
John Harsh, PhD: Exploring Once-Nightly Sodium Oxybate Therapy for Narcolepsy
John Harsh, PhD
© 2024 MJH Life Sciences

All rights reserved.